Synthesis of novel nicotinohydrazide and (1,3,4-oxadiazol-2-yl)-6-(trifluoromethyl)pyridine derivatives as potential anticancer agents

Add time:09/02/2019    Source:sciencedirect.com

A series of novel nicotinohydrazide derivatives 6a–g and 1,3,4-oxadiazole functionalized pyridine derivatives 7a–k and 8a–d were prepared in series of steps. All the compounds were screened for cytotoxicity against HeLa (cervical), DU145 (prostate), HepG2 (liver) and MBA-MB-231 (breast) human cancer cell lines. Compounds 6h, 6i, 7d, 7h, 7i and 8b which showed promising cytotoxicity at <15 μM concentration have been identified. Further optimization of the structure is underway to identify a lead compound.

We also recommend Trading Suppliers and Manufacturers of Methyl 2-(trifluoromethyl)nicotinate (cas 136483-17-5). Pls Click Website Link as below: cas 136483-17-5 suppliers

Prev:Monitoring Abacavir (cas 136470-78-5) bioactivation in humans: Screening for an aldehyde metabolite
Next:Article (Special Issue on Electrocatalysis Transformation)Photoelectrochemical degradation of acetaminophen and valacyclovir using nanoporous titanium dioxide)